Small Molecule Targeted Cancer Therapy Market By Therapy Type (Kinase Inhibitors, PARP Inhibitors, Apoptosis Inducers); By Cancer Type (Lung Cancer, Breast Cancer, Melanoma, Colorectal Cancer, Hematologic Cancers, Others); By Route of Administration (Oral, Injectable); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Small Molecule Targeted Cancer Therapy Market will witness a promising CAGR of 7.3% , valued at approximately $64.5 billion in 2024 , and is projected to reach around Read More

Published Date: NOV-2025 | No Of Pages:177 | $ 4485

Neuroprotection Market By Product Type (Drugs, Devices); By Therapeutic Application (Neurodegenerative Diseases, Traumatic Brain Injury, Stroke and Ischemic Disorders); By End User (Hospitals & Clinics, Research Institutions, Contract Research Organizations, Home Care Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Neuroprotection Market will experience substantial growth, driven by a surge in demand for therapies targeting neurodegenerative diseases and the increasing burden of neurological disorders. In 202... Read More

Published Date: NOV-2025 | No Of Pages:158 | $ 4485

Circadian Rhythm Sleep Treatment Market By Treatment Type (Pharmacological Therapies, Non-Pharmacological Therapies); By Disorder Type (Delayed Sleep Phase Disorder, Advanced Sleep Phase Disorder, Non-24-Hour Sleep-Wake Disorder, Shift Work Sleep Disorder, Jet Lag Disorder); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Circadian Rhythm Sleep Treatment Market will witness a steady CAGR of 6.2%, valued at $1.72 billion in 2024, expected to grow and reach $2.61 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Aortic Stenosis Treatment Market By Treatment Type (Surgical Aortic Valve Replacement, Transcatheter Aortic Valve Replacement, Balloon Aortic Valvuloplasty, Medications); By End-User (Hospitals, Specialized Cardiac Clinics, Ambulatory Surgical Centers, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Aortic Stenosis Treatment Market is expected to grow significantly, driven by increasing global awareness of cardiovascular diseases and the growing aging population. In 2024, the market i... Read More

Published Date: NOV-2025 | No Of Pages:162 | $ 4485

Postherpetic Neuralgia (PHN) Treatment Market By Treatment Type (Oral Medications, Topical Treatments, Injectables); By Drug Class (Anticonvulsants, Tricyclic Antidepressants, Opioids, Others); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Postherpetic Neuralgia (PHN) Treatment Market will witness a robust growth with an estimated CAGR of 5.1%Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Compartment Syndrome Monitoring Market By Product Type (Pressure Monitoring Systems, Wearable Sensors, Diagnostic Kits); By Application (Trauma & Emergency Care, Post-Surgical Monitoring, Military & Field Applications); By End User (Hospitals & Trauma Centers, Ambulatory Surgical Centers, Emergency Medical Services, Military); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Compartment Syndrome Monitoring Market is anticipated to experience a significant growth trajectory, with an expected CAGR of 7.2% , projected to reach Read More

Published Date: NOV-2025 | No Of Pages:150 | $ 4485

Trauma Care Centers Market By Facility Type (Level I, Level II & III, Mobile & Rural Units); By Injury Type (Road Traffic, Falls, Penetrating/Blunt, Burn & Chemical); By End User (Public Hospitals, Private Trauma Facilities, Military & Defense, Academic Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Trauma Care Centers Market will witness a steady CAGR of 6.3% , valued at $24.5 billion in 2024 , expected to appreciate and reach appro... Read More

Published Date: NOV-2025 | No Of Pages:188 | $ 4485

Progressive Multifocal Leukoencephalopathy (PML) Treatment Market By Treatment Type (Drug Therapies, Biologic Treatments); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Progressive Multifocal Leukoencephalopathy (PML) Treatment Market is poised for notable growth, projected to expand at a CAGR of 8.5% from 2024 to 2030 , with an estimated market value of ... Read More

Published Date: NOV-2025 | No Of Pages:184 | $ 4485

Bioidentical Hormones Market By Product Type (Hormone Replacement Therapies, Compounded Hormones); By Application (Menopause Treatment, Andropause Treatment, Thyroid Disorders, Other Applications); By End User (Pharmaceutical Companies, Compounding Pharmacies, Wellness Centers, Hospitals); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Bioidentical Hormones Market is poised for strong growth in the 2024-2030 period, driven by increasing demand for hormone replacement therapies (HRT) that use hormones structurally identical to those the b... Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Clostridium Difficile Infection Treatment Market By Treatment Type (Antibiotics, Immunotherapies, Microbiota Restoration Therapies, Others); By Route of Administration (Oral, Intravenous, Rectal); By End User (Hospitals, Ambulatory Surgical Centers, Long-Term Care Facilities, Home Healthcare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Clostridium Difficile Infection ( CDI ) Treatment Market is projected to grow at a CAGR of 5.9 ... Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Peptide Receptor Radionuclide Therapy (PRRT) Market By Product Type (Radiopharmaceuticals, Peptides); By Application (Neuroendocrine Tumors, Other Cancers); By End-User (Hospitals, Research Institutions, CROs, Imaging Centers); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Peptide Receptor Radionuclide Therapy (PRRT) market is anticipated to experience a notable growth trajectory from 2024 to 2030 , driven by an increasing focus on advanced cancer treatments. The m... Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Fibroblast Growth Factor Receptor (FGFR) Inhibitor Market By Drug Type (Selective Inhibitors, Pan-FGFR Inhibitors); By Application (Cancer Treatment, Other Therapies); By End User (Hospitals, Cancer Research Institutes, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fibroblast Growth Factor Receptor ( FGFR ) Inhibitor Market is poised for substantial growth, with a projected Read More

Published Date: NOV-2025 | No Of Pages:163 | $ 4485

Autologous Conditioned Plasma Market By Product Type (Pure PRP Systems, Leukocyte-Rich PRP Systems); By Application (Orthopedic & Sports Injuries, Aesthetic Medicine, Wound Healing, Dental Surgery, Veterinary); By End User (Hospitals, Specialty Clinics, Research Institutes, Homecare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Autologous Conditioned Plasma Market will witness a robust CAGR of 8.86 % , valued at $980 million in 2024 , and is expected to appreciate and reach near... Read More

Published Date: NOV-2025 | No Of Pages:151 | $ 4485

Psychotic Disorder Treatment Market By Drug Class (Atypical Antipsychotics, Typical Antipsychotics, Novel Mechanism Drugs); By Treatment Modality (Pharmacological, Psychotherapy, Digital Therapeutics, Community-Based Programs); By End User (Psychiatric Hospitals, Outpatient Clinics, Community Mental Health Centers, Digital Health Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Psychotic Disorder Treatment Market will witness a moderate but steady CAGR of 5.2% , valued at $13.2 billion in 2024 , expected to reach... Read More

Published Date: NOV-2025 | No Of Pages:169 | $ 4485

Radioimmunotherapy Market By Product Type (Monoclonal Antibodies, Radiopharmaceuticals); By Application (Cancer Treatment, Diagnostic Imaging); By End-User (Hospitals & Oncology Centers, Pharmaceutical & Biotech Companies, Research Institutions, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Radioimmunotherapy Market is poised to experience steady growth from 2024 to 2030 , with a forecasted CAGR of 7.2% . Valued at USD 1.6 billion in 2024 , the market is expe... Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Triple Negative Breast Cancer Treatment Market By Treatment Type (Chemotherapy, Immunotherapy, Targeted Therapy, Others); By Treatment Setting (Early-Stage, Metastatic/Advanced); By Distribution Channel (Hospitals & Oncology Clinics, Specialty Cancer Centers, Outpatient & Home Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Triple Negative Breast Cancer ( TNBC ) Treatment Market is set to grow steadily, with an estimated CAGR of around 8.5% , reaching a valuation near Read More

Published Date: NOV-2025 | No Of Pages:165 | $ 4485

Alcoholic Hepatitis Treatment Market By Treatment Type (Pharmacological Treatments, Liver Transplantation, Emerging Therapies); By Drug Class (Corticosteroids, Pentoxifylline, Immunosuppressive Drugs); By Route of Administration (Oral, Parenteral); By End-User (Hospitals, Outpatient Clinics, Research Institutes, CROs); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Alcoholic Hepatitis Treatment Market is set to grow rapidly over the forecast period of 2024–2030 , driven by increasing cases of liver diseases linked to alcohol consumption and the growing demand f... Read More

Published Date: NOV-2025 | No Of Pages:182 | $ 4485

Urinary Tract Infection Treatment Market By Drug Type (Quinolones, Beta-lactam & Cephalosporins, Sulfonamides, Tetracyclines, Aminoglycosides, Others); By Clinical Type (Uncomplicated UTI, Complicated UTI, Recurrent UTI, Catheter-Associated UTI); By End User (Hospitals, Retail Pharmacies, Clinics, Online Providers & Telemedicine); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Urinary Tract Infection ( UTI ) Treatment Market will witness a steady CAGR of 4.6% , valued at $10.4 billion in 2024 , and projected to ... Read More

Published Date: NOV-2025 | No Of Pages:155 | $ 4485

Transplantation Market By Product Type (Solid Organ Transplants, Bone Marrow Transplants, Corneal Transplants); By Application (End-Stage Organ Failure, Cancer Treatment, Ophthalmic Treatments); By End User (Hospitals & Transplant Centers, Research Institutions, Pharmaceutical Companies, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Transplantation Market will witness a steady compound annual growth rate (CAGR) of 4.5% , valued at USD 22.3 billion in 2024, and is expected to reach USD 29.5 bil... Read More

Published Date: NOV-2025 | No Of Pages:196 | $ 4485

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market By Drug Type (Biologics, Immunosuppressants); By Treatment Approach (First-Line Therapies, Second-Line Therapies); By Route of Administration (Intravenous, Subcutaneous); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Treatment Market is poised for steady growth, with the market expected to expand at a CAGR of 5.1% between 2024 and 2030. Valued at... Read More

Published Date: NOV-2025 | No Of Pages:186 | $ 4485

Cardiac Arrest Treatment Market By Product Type (Defibrillators, CPR Devices, Emergency Drugs, Airway Equipment, Circulatory Support); By Treatment (Basic Life Support, Advanced Cardiovascular Life Support, Targeted Temperature Management, Extracorporeal CPR); By End User (Hospitals, EMS, Public Facilities, Military, Ambulatory Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Cardiac Arrest Treatment Market will witness a robust CAGR of 8.4% , valued at $7.8 billion in 2024 , expected to expand and reach around $13.5 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:181 | $ 4485

Liver Metastasis Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Surgery); By End User (Hospitals, Oncology Clinics, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Liver Metastasis Treatment Market is set to experience strong growth, with a CAGR of 8.4% from 2024 to 2030. The market, valued at USD 5.2 billion in 2024... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Coagulation Factor Deficiency Market By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease); By Treatment Modality (Factor Replacement Therapy, Gene Therapy, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Coagulation Factor Deficiency Market will witness a robust CAGR of 7.5% , valued at USD 11.5 billion in 2024 , and is projected to grow to USD 17.5 billion by 203... Read More

Published Date: NOV-2025 | No Of Pages:193 | $ 4485

Bleeding Disorders Treatment Market By Product Type (Coagulation Factors, Gene Therapies, Others); By Disease Type (Hemophilia A, Hemophilia B, Von Willebrand Disease, Others); By End-User (Hospitals, Specialized Treatment Centers, CROs, Home Care Providers); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Bleeding Disorders Treatment Market will experience steady growth, projected to reach a value of USD 14.9 billion by 2030 , up from USD 10.8 billi... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Hemophilia Gene Therapy Market By Therapy Type (AAV-Based Therapies, CRISPR-Based Therapies); By Hemophilia Type (Hemophilia A, Hemophilia B); By End User (Pharmaceutical & Biotech Companies, Healthcare Providers, CROs, Academic Institutions); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hemophilia Gene Therapy Market is poised to experience remarkable growth, driven by significant advances in gene therapy technologies and an increasing demand for innovati... Read More

Published Date: NOV-2025 | No Of Pages:159 | $ 4485

Mantle Cell Lymphoma (MCL) Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation, Combination Therapy); By End-User (Hospitals & Clinics, Research Institutions, CROs, Academic & Community Oncology Practices); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mantle Cell Lymphoma (MCL) Treatment Market is expected to experience a notable growth trajectory, with a projected market value of USD 5.3 billion in 2024 , expanding to USD 7.9 b... Read More

Published Date: NOV-2025 | No Of Pages:168 | $ 4485

Pelvic Congestion Syndrome Treatment Market By Treatment Type (Minimally Invasive Procedures, Pharmacological Treatments, Surgical Treatments); By End User (Hospitals, Outpatient Clinics, Specialty Centers, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Pelvic Congestion Syndrome (PCS) Treatment Market will witness a solid growth trajectory, with a projected CAGR of 7.5% from 2024 to 2030. The market is estimated to be valued at U... Read More

Published Date: NOV-2025 | No Of Pages:164 | $ 4485

Cardiac Resynchronization Therapy Market By Product Type (CRT-P, CRT-D); By Application (Heart Failure with Reduced Ejection Fraction, Atrial Fibrillation, Post-Myocardial Infarction); By End User (Hospitals, Ambulatory Surgical Centers, Cardiologists & Clinics, Contract Research Organizations); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Cardiac Resynchronization Therapy (CRT) Market is positioned for steady growth, with a CAGR of 8.2% from 2024 to 2030Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Stroke Rehabilitation Market By Rehabilitation Method (Physical Therapy, Occupational Therapy, Speech Therapy, Neurostimulation); By Product Type (Therapeutic Devices, Wearable Technology, Therapeutic Software, Others); By End-User (Hospitals and Rehabilitation Centers, Home Care Settings, CROs, Forensic and Environmental Labs); By Region, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Stroke Rehabilitation Market is set to witness substantial growth, projected to expand with a robust CAGR of 7.6% , valued at approximately $24.5 billion in 2024Read More

Published Date: NOV-2025 | No Of Pages:157 | $ 4485

Spinal Stenosis Market By Treatment Type (Surgical, Non-Surgical); By Type of Stenosis (Lumbar, Cervical, Thoracic); By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Spinal Stenosis Market will expand at a compelling CAGR of 7.1% , valued at $7.4 billion in 2024 , and is projected to reach around $11.9 billion by 2030 ... Read More

Published Date: NOV-2025 | No Of Pages:156 | $ 4485

Human Chorionic Gonadotropin (hCG) Market By Product Type (Injectables, Oral, Test Kits); By Application (Fertility Treatments, Weight Management, Pregnancy Testing); By End User (Fertility Clinics, Pharmaceutical Companies, Diagnostic Laboratories, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Human Chorionic Gonadotropin ( Hcg ) Market is expected to experience significant growth during the forecast period of 2024 to 2030. The market, valued at USD Read More

Published Date: NOV-2025 | No Of Pages:152 | $ 4485

Artificial Insemination Market By Methodology (Intrauterine Insemination, Intracervical Insemination, Intracytoplasmic Sperm Injection); By Application (Human Fertility, Animal Breeding); By End User (Fertility Clinics, Hospitals, Veterinary Clinics, Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Artificial Insemination Market is expected to witness a steady growth trajectory in the coming years. Valued at USD 1.5 billion in 2024, it is projected to grow at a CAGR of 7.5%Read More

Published Date: NOV-2025 | No Of Pages:187 | $ 4485

Therapeutic Apheresis Market By Procedure Type (Plasmapheresis, Leukapheresis, Plateletpheresis, Erythrocytapheresis); By Application (Autoimmune Diseases, Neurological Disorders, Hematologic Disorders, Renal Disorders); By End User (Hospitals, Ambulatory Surgical Centers, Blood Donation Centers, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Therapeutic Apheresis Market will witness a solid compound annual growth rate (CAGR) of 7.3% , valued at USD 3.2 billion in 2024. This market is projected to reach Read More

Published Date: NOV-2025 | No Of Pages:185 | $ 4485

Nerve Repair Market By Product Type (Nerve Grafts, Neurostimulation Devices, Stem Cell Therapies, Nerve Conduits, Others); By Application (Traumatic Nerve Injury, Neurodegenerative Diseases, Diabetic Neuropathy, Others); By End-User (Hospitals, Neurology Clinics, Research Institutes, CROs, Others); By Region, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Nerve Repair Market is poised for substantial growth, with a projected CAGR of 8.6% , valued at USD 12.5 billion in 2024 , and expected to reach USD 19.5 billion b... Read More

Published Date: NOV-2025 | No Of Pages:190 | $ 4485

Gene Therapy Market By Vector Type (Viral Vectors [AAV, Lentivirus, Retrovirus], Non-Viral Vectors [Lipid Nanoparticles, Plasmids]); By Indication (Monogenic Disorders, Oncology, Ophthalmology, Neurology); By Delivery Method (In Vivo, Ex Vivo); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Gene Therapy Market will witness a robust CAGR of 22.3%, valued at $12.4 billion in 2024, expected to appreciate and rea... Read More

Published Date: NOV-2025 | No Of Pages:198 | $ 4485

Viscosupplementation Market By Product Type (Single Injection, Multiple Injection, Combination Products); By End User (Orthopedic Clinics, Hospitals, Physiotherapy Centers); By Application (Knee Osteoarthritis, Hip Osteoarthritis, Other Joint Applications); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Viscosupplementation Market will experience steady growth over the forecast period from 2024 to 2030 , driven by increasing demand for minimally invasive ... Read More

Published Date: NOV-2025 | No Of Pages:171 | $ 4485

Arteriovenous Fistula Treatment Market By Treatment Type (Surgical AVF Creation, Percutaneous AVF Creation); By Surgical Method (End-to-End Anastomosis, Side-to-Side Anastomosis); By End User (Hospitals & Dialysis Centers, Outpatient Surgery Centers, Dialysis Clinics, Academic & Research Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Arteriovenous Fistula (AVF) Treatment Market will experience significant growth during the forecast period from 2024 to 2030 , with a projected CAGR of 8.4Read More

Published Date: NOV-2025 | No Of Pages:194 | $ 4485

Hereditary Angioedema Therapeutics Market By Treatment Type (On-Demand, Prophylactic); By Route of Administration (Injectable, Oral); By Distribution Channel (Hospital Pharmacies, Specialty Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hereditary Angioedema (HAE) Therapeutics Market is projected to grow at a robust CAGR of 8.6% , reaching approximately $5.2 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:199 | $ 4485

Aspergillosis Treatment Market By Type of Aspergillosis (Invasive, Chronic Pulmonary, Allergic Bronchopulmonary); By Treatment Type (Antifungal Drugs, Surgical Intervention, Combination Therapies); By Distribution Channel (Hospitals, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Aspergillosis Treatment Market is positioned for notable growth over the forecast period of 2024–2030 . The market is expected to grow from $2.76 billion in 2024 to Read More

Published Date: NOV-2025 | No Of Pages:160 | $ 4485

Personalized Cancer Vaccines Market By Vaccine Type (Neoantigen-Based, Dendritic Cell, RNA-Based); By Cancer Type (Melanoma, Lung Cancer, Glioblastoma, Colorectal Cancer, Others); By End User (Academic & Research Institutes, Hospitals & Cancer Centers, Biotechnology & Pharma Companies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Personalized Cancer Vaccines Market will witness a robust CAGR of 19.8% , valued at $3.2 billion in 2024 , expected to appreciate and reach $9.5 billion by 2030Read More

Published Date: NOV-2025 | No Of Pages:166 | $ 4485

Narcolepsy Therapeutics Market By Product Type (CNS Stimulants, Sodium Oxybate-Based Therapies, Selective Histamine H3 Receptor Antagonists/Inverse Agonists, Orexin Receptor Agonists); By Type (Type 1 Narcolepsy, Type 2 Narcolepsy); By Route of Administration (Oral, Oral Liquid, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Narcolepsy Therapeutics Market will witness a robust CAGR of 8.4% , valued at $3.1 billion in 2024, expected to appreciate and reach $5.0 billion<... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Gaucher Disease Drugs Market By Product Type (Enzyme Replacement Therapy [ERT], Substrate Reduction Therapy [SRT], Gene Therapy, Other Therapies); By Treatment Type (Pharmacological Treatments, Gene Therapy); By Distribution Channel (Hospital Pharmacies, Specialty Clinics, Online Pharmacies, Research Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Gaucher Disease Drugs Market will witness a robust CAGR of 8.82 % , valued at USD 2.9 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

Pigmentation Disorder Treatment Market By Product Type (Topical Products, Oral Medications, Injectable Treatments, Laser and Light Therapy); By Treatment Method (Pharmacological Treatments, Cosmetic Procedures, Light-based Treatments); By End User (Clinics and Dermatology Centers, Aesthetic Clinics, Home Care); By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Pigmentation Disorder Treatment Market will see significant growth from 2024 to 2030, driven by increasing awareness of skin conditions, rising demand for cosmetic treatments, and advancements in medical therapie... Read More

Published Date: OCT-2025 | No Of Pages:161 | $ 4485

Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market By Therapeutic Approach (First-Line, Second-Line, Other Treatments); By Drug Type (Biologics, Oral Therapies, IVIG & Steroids); By Route of Administration (Injectables, Oral Medications); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Thrombocytopenic Purpura (ITP) Therapeutics Market is expected to experience steady growth, with an estimated market value of $1.3 billion in 2024 , projected t... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

Mouth Ulcer Treatment Market By Product Type (Corticosteroids, Antihistamines, Analgesics & Anesthetics, Antimicrobial Mouthwashes & Rinses, Nutritional Supplements, Natural & Herbal Products); By Route of Administration (Topical, Oral Systemic); By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Mouth Ulcer Treatment Market will witness a robust CAGR of 5.6% , valued at approximately $1.8 billion in 2024 , expecte... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Genitourinary Drugs Market By Drug Class (Hormonal Therapies, Anti-Infectives, Oncology Drugs, BPH Therapies, Erectile Dysfunction Drugs, Overactive Bladder Treatments, Others); By Route of Administration (Oral, Parenteral, Topical/Transdermal, Intravesical); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Genitourinary Drugs Market will witness a robust CAGR of 6.8% , valued at $45.2 billion in 2024, expected to appreciate ... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Critical Limb Ischemia Treatment Market By Treatment Type (Endovascular Treatment, Surgical Treatment, Pharmacological Treatment); By End User (Hospitals & Cardiovascular Centers, Clinics & ASCs, Other End Users); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Critical Limb Ischemia (CLI) Treatment Market will experience significant growth over the forecast period from 2024 to 2030, driven by advancements in medical technologies, an increasing global prevalence of vasc... Read More

Published Date: OCT-2025 | No Of Pages:150 | $ 4485

Autism Spectrum Disorder Treatment Market By Treatment Type (Pharmacological, Behavioral Therapies, Assistive Technologies, Digital Therapeutics, Complementary & Alternative Treatments); By Age Group (Children, Adolescents, Adults); By Distribution Channel (Hospitals & Clinics, Specialty Centers, Online Platforms, Home-Based Care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Autism Spectrum Disorder (ASD) Treatment Market will witness a robust CAGR of 7.6% , valued at $3.42 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:186 | $ 4485

Retinal Vein Occlusion (RVO) Treatment Market By Drug Class (Anti-VEGF Agents, Corticosteroids, Combination Therapies); By Disease Type (Central Retinal Vein Occlusion, Branch Retinal Vein Occlusion); By Distribution Channel (Hospital Pharmacies, Retail & Specialty Pharmacies, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Retinal Vein Occlusion (RVO) Treatment Market will witness a robust CAGR of 6.8% , valued at $1... Read More

Published Date: OCT-2025 | No Of Pages:171 | $ 4485

Primary Biliary Cholangitis (PBC) Market By Drug Type (Ursodeoxycholic Acid, Obeticholic Acid, and Other Drugs); By Route of Administration (Oral, Injectable); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Biliary Cholangitis (PBC) Market will witness a robust CAGR of 8.01 % , valued... Read More

Published Date: OCT-2025 | No Of Pages:174 | $ 4485

Nicotine Replacement Therapy Market By Product Type (Gum, Patch, Inhaler, Nasal Spray, Lozenges); By Route of Administration (Oral, Nasal, Transdermal, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies & Drug Stores, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Nicotine Replacement Therapy (NRT) Market will witness a robust CAGR of 6.7%, valued at $3.86 billion in 2024 , expected to appreciate an... Read More

Published Date: OCT-2025 | No Of Pages:163 | $ 4485

Relapsed and Refractory Multiple Myeloma Treatment Market Relapsed and Refractory Multiple Myeloma (RRMM) Treatment Market By Treatment Modality (Immunomodulatory Drugs, Proteasome Inhibitors, Monoclonal Antibodies, CAR-T Cell Therapy, Bispecific Antibodies); By Line of Therapy (Second-Line Therapy, Third-Line and Beyond); By Route of Administration (Oral, Intravenous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Relapsed And Refractory Multiple Myeloma Treatment Market will witness a robust CAGR of 7.4% , valued at $16.8 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:160 | $ 4485

Ovarian Cancer Drugs Market By Drug Type (Chemotherapy Drugs, Targeted Therapy Drugs, Immunotherapy Drugs); By Treatment Approach (First-Line Treatment, Second-Line Treatment, Adjuvant Therapy); By Region (North America, Europe, Asia Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Ovarian Cancer Drugs Market will witness a robust CAGR of 7.6% , valued at $5.3 billion in 2024 , and is projected to reach $9.2 ... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Tuberculosis Therapeutics Market By Drug Class (First-Line Therapy, Second-Line Therapy); By Disease Type (Active TB, Latent TB); By Route of Administration (Oral, Injectable); By Distribution Channel (Public Programs, Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Tuberculosis Therapeutics Market will witness a steady CAGR of 6.1% , valued at $1.34 billion in 2024 , and is expected to reach $1.91 billion by 2030 , c... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Iron Deficiency Anemia Therapy Market By Therapy Type (Oral Iron Supplements, Intravenous Iron Therapy, Erythropoiesis-Stimulating Agents); By Route of Administration (Oral, Intravenous); By End User (Hospitals, Clinics, Homecare, Specialty Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Iron Deficiency Anemia Therapy Market will witness a robust CAGR of 8.1% , valued at USD 3.9 billion in 2024 , expected to appreciate and reach US... Read More

Published Date: OCT-2025 | No Of Pages:153 | $ 4485

Herpes Simplex Virus Treatment Market by Treatment Type (Antiviral Drugs, Vaccines); By Type of Infection (HSV-1, HSV-2); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Herpes Simplex Virus ( HSV ) Treatment Market is poised for significant growth, expected to grow at a CAGR of 5.7% valued at USD 9.8 billionRead More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Substance Abuse Treatment Market By Treatment Type (Medication-Assisted Treatment, Behavioral Therapies & Counseling, Residential/Inpatient Treatment, Outpatient Treatment Programs); By Substance Type (Alcohol Dependence, Opioid Dependence, Cannabis Use Disorder, Cocaine and Stimulant Addiction, Prescription Drug Abuse, Others); By End User (Hospitals, Specialty Rehabilitation Centers, Private Clinics and Individual Practitioners, Government & Community Organizations, Telehealth and Digital Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Substance Abuse Treatment Market will witness a robust CAGR of 6.8% , valued at $21.3 billion in 2024 , expected to appreciate and reach $31.7 billion by 2030Read More

Published Date: OCT-2025 | No Of Pages:170 | $ 4485

Non-Hodgkin Lymphoma (NHL) Therapeutics Market By Therapy Type (Chemotherapy, Immunotherapy, Targeted Therapy, Stem Cell Transplantation); By Indication (B-cell NHL, T-cell NHL); By End-User (Hospitals, Oncology Clinics, Research Centers, Outpatient Treatment Centers); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction and Strategic Context

The global Non-Hodgkin Lymphoma (NHL) Therapeutics Market is expected to experience robust growth, reaching a market value of $15.2 billion in 2024 and growing to $32.5 billion by 20... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Tourette Syndrome Treatment Market By Treatment Type (Pharmacological Treatments, Behavioral Therapy, Surgical Interventions); By Drug Class (Antipsychotic Drugs, Alpha-2 Adrenergic Agonists, Anticonvulsants, Others); By End User (Hospitals & Clinics, Specialty Care Centers, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Tourette Syndrome Treatment Market is expected to witness a robust compound annual growth rate (CAGR) of 6.5% , with a market value of USD 1.2 bil... Read More

Published Date: OCT-2025 | No Of Pages:167 | $ 4485

Retinoblastoma Treatment Market By Treatment Type (Chemotherapy, Radiation Therapy, Surgery, Targeted Therapy, Gene Therapy); By Disease Stage (Localized, Metastatic); By Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Retinoblastoma Treatment Market is projected to experience significant growth, driven by ongoing advancements in medical technology, early diagnosis, and increasing awareness of the condition. Retinoblastoma, a r... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Pseudomonas Aeruginosa Infection Treatment Market By Drug Class (Beta-lactam Antibiotics, Aminoglycosides, Fluoroquinolones, Biologics, Phage Therapy, Combination Therapies); By Route of Administration (Injectable, Oral, Inhaled, Topical); By Indication Type (HAP & VAP, UTIs, BSIs, Cystic Fibrosis, Surgical Site Infections); By End User (Hospitals, Clinics, Outpatient, Military Units); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pseudomonas Aeruginosa Infection Treatment Market will witness a promising CAGR of 7.2% , valued at USD 5.8 billion in 2024 , and is expected to reach around USD 9... Read More

Published Date: OCT-2025 | No Of Pages:200 | $ 4485

Sarcoma Drugs Market By Drug Type (Chemotherapy, Targeted Therapy, Immunotherapy); By Therapeutic Approach (Adjuvant, Neoadjuvant); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Sarcoma Drugs Market is projected to witness a steady growth rate, with an anticipated CAGR of 7.3% from 2024 to 2030. Valued at $2.5 billion in 2024, it ... Read More

Published Date: OCT-2025 | No Of Pages:155 | $ 4485

Malignant Glioma Therapeutics Market By Therapeutic Type (Chemotherapy, Immunotherapy, Targeted Therapy); By Drug Class (Chemotherapeutic Agents, Monoclonal Antibodies, Immunomodulatory Agents); By End User (Hospitals, Specialized Oncology Centers, Research Institutions); By Region (North America, Europe, Asia-Pacific, LAMEA); Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Malignant Glioma Therapeutics Market will witness a robust growth trajectory, with a projected compound annual growth rate ( CAGR ) of 8.5% . Valued at Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Glioblastoma Multiforme Treatment Market By Treatment Type (Surgical Procedures, Chemotherapy, Radiation Therapy, Targeted Therapies, Immunotherapies); By End-User (Hospitals, Clinics, Research Centers, Oncology Centers); By Region (North America, Europe, Asia-Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Glioblastoma Multiforme ( GBM ) Treatment Market is anticipated to exhibit robust growth over the forecast period from 2024 to 2030. Glioblastom... Read More

Published Date: OCT-2025 | No Of Pages:151 | $ 4485

Peripheral T-cell Lymphoma (PTCL) Treatment Market By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Disease Subtype (PTCL-NOS, AITL, ALCL, Others); By Route of Administration (Oral, Injectable); By End User (Hospitals, Cancer Specialty Clinics, Academic & Research Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Peripheral T -Cell Lymphoma (PTCL) Treatment Market will witness a robust CAGR of 7.4%, valued at $1.61 billion ... Read More

Published Date: OCT-2025 | No Of Pages:156 | $ 4485

Graft Versus Host Disease (GVHD) Treatment Market By Treatment Type (Corticosteroids, Monoclonal Antibodies, JAK Inhibitors, Calcineurin Inhibitors, Extracorporeal Photopheresis, Others); By Disease Type (Acute GVHD, Chronic GVHD); By Route of Administration (Oral, Intravenous, Topical); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Graft Versus Host Disease (GVHD) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.2 billion in 2024 , and is expected t... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Scleroderma Therapeutics Market By Drug Class (Immunosuppressants, Monoclonal Antibodies, Tyrosine Kinase Inhibitors, Others); By Route of Administration (Oral, Parenteral, Topical); By Disease Type (Localized Scleroderma, Systemic Scleroderma, SSc-PAH, Renal Involvement); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Scleroderma Therapeutics Market will witness a robust CAGR of 6.6% , valued at $3.42 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:172 | $ 4485

Neglected Tropical Disease (NTD) Treatment Market Neglected Tropical Disease Treatment Market By Drug Type (Antiparasitic, Antibacterial, Antiviral, Supportive Therapies, Vaccines); By Disease Type (Leishmaniasis, Chagas Disease, Lymphatic Filariasis, Schistosomiasis, Onchocerciasis, Others); By Route of Administration (Oral, Parenteral, Topical, Inhalational); By Distribution Channel (Government Programs, Hospitals, Pharmacies, NGOs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Neglected Tropical Disease Treatment Market will witness a robust CAGR of 8.9% , valued at $2.78 billion in 2024 , and is expected to appreciate and ... Read More

Published Date: OCT-2025 | No Of Pages:166 | $ 4485

Hairy Cell Leukemia Market By Treatment Modality (Purine Analogs, BRAF Inhibitors, Monoclonal Antibodies, Other Combination Therapies); By Diagnostic Technology (Flow Cytometry, Molecular Testing, Immunohistochemistry); By End User (Specialty Oncology Centers, Academic & Research Hospitals, Community Hematology Clinics); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Hairy Cell Leukemia Market will witness a robust CAGR of 7.23 % , valued at $0.78 billion in 2024 , exp... Read More

Published Date: OCT-2025 | No Of Pages:180 | $ 4485

NUT Midline Carcinoma Treatment Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Surgery); By Route of Administration (Oral, Intravenous, Others); By Diagnostic Method (IHC, FISH, NGS, PCR); By End User (Hospitals & Academic Medical Centers, Specialty Cancer Clinics, Diagnostic Laboratories, CROs); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global NUT Midline Carcinoma Treatment Market will witness a robust CAGR of 16.3%, valued at around $48.2 million in 2024,... Read More

Published Date: OCT-2025 | No Of Pages:187 | $ 4485

Skeletal Dysplasia Market By Type of Disorder (Achondroplasia, Hypophosphatasia, Osteogenesis Imperfecta, Thanatophoric Dysplasia, Others); By Treatment Modality (Pharmacological Therapy, Surgical Intervention, Gene Therapy, Assistive Devices); By Diagnostic Technique (Radiographic Imaging, Genetic Testing, Prenatal Diagnosis); By End User (Hospitals, Specialized Clinics, Diagnostic Labs, Academic Institutions); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Skeletal Dysplasia Market will witness a robust CAGR of 7.8% , valued at $2.14 billion in 2024 , and is expected to appreciate and reach $3.37 bil... Read More

Published Date: OCT-2025 | No Of Pages:198 | $ 4485

Antisense and RNAi Therapeutics Market By Therapeutic Type (Antisense Oligonucleotides, RNA Interference); By Application (Genetic Disorders, Oncology, Neurodegenerative Diseases, Ophthalmology, Infectious Diseases); By Route of Administration (Intravenous, Subcutaneous, Intrathecal, Others); By End User (Biopharmaceutical Companies, Hospitals, Specialty Clinics, Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Antisense And RNAi Therapeutics Market will witness a robust CAGR of 17.4% , valued at $5.8 billion in 2024 , expected t... Read More

Published Date: OCT-2025 | No Of Pages:196 | $ 4485

Acute Lymphocytic Lymphoblastic Leukemia Therapeutics Market Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, Stem Cell Transplantation); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Oncology Clinics, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Acute Lymphocytic (Lymphoblastic) Leukemia Therapeutics Market will witness a robust CAGR of 8.7% , valued at $3.5 Read More

Published Date: OCT-2025 | No Of Pages:175 | $ 4485

Estrogen Receptor Positive (ER+) Breast Cancer Treatment Market By Drug Class (SERMs, Aromatase Inhibitors, SERDs, CDK4/6 Inhibitors, PI3K/AKT/mTOR Inhibitors, Others); By Line of Therapy (Adjuvant, Neoadjuvant, Metastatic/Advanced); By Route of Administration (Oral, Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Estrogen Receptor Positive (ER +) Breast Cancer Treatment Market will witness a robust CAGR of 6.5 % , ... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Artemisinin Combination Therapy Market By Drug Combination Type (Artemether-Lumefantrine, Artesunate-Amodiaquine, DHA-Piperaquine, Artesunate-Mefloquine, Others); By Route of Administration (Oral, Parenteral, Rectal Suppositories); By End User (Public Health Systems, Private Hospitals, NGOs, Pharmacies); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Artemisinin Combination Therapy Market will witness a robust CAGR of 6.8% , valued at $2.42 billion in 2024 , and is expected to appreciate and reach $3.6 billion ... Read More

Published Date: OCT-2025 | No Of Pages:178 | $ 4485

Periodontal Therapeutics Market By Product Type (Systemic Antibiotics, Local Antibiotic Delivery Agents, Anti-inflammatory Agents, Regenerative Therapeutics, Host Modulation Agents, Others); By Mode of Administration (Oral, Injectable, Topical); By End User (Dental Clinics, Hospitals, Academic & Research Institutions, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Periodontal Therapeutics Market will witness a robust CAGR of 6.5% , valued at $8.4 billion in 2024 , and is expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:154 | $ 4485

Fabry Disease Treatment Market By Treatment Type (Enzyme Replacement Therapy, Pharmacological Chaperones, Gene Therapy, Substrate Reduction Therapy); By Route of Administration (Intravenous, Oral); By End User (Hospitals & Infusion Centers, Specialty Clinics & Genetic Centers, Home Healthcare); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Fabry Disease Treatment Market will witness a robust CAGR of 11.4% , valued at $2.15 billion in 2024, expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:182 | $ 4485

Cystic Fibrosis Therapeutics Market By Drug Type (CFTR Modulators, Antibiotics, Mucolytics, Others); By Route of Administration (Oral, Inhalation, Injectables); By End User (Hospitals, Pharmacies, Home Care, Research Institutions); By Region (North America, Europe, Asia Pacific, LAMEA), Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Cystic Fibrosis Therapeutics Market is positioned to grow at a robust CAGR of 8.5% , valued at $5.4 billion in 2024 , and is expected to ... Read More

Published Date: OCT-2025 | No Of Pages:169 | $ 4485

Irritable Bowel Syndrome Treatment Market By Product Type (Prescription Drugs, Over-the-Counter Drugs, Probiotics, Digital Therapeutics); By IBS Subtype (IBS-C, IBS-D, IBS-M, IBS-U); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online, Telehealth Platforms); By End User (Hospitals, Gastroenterology Clinics, ASCs, Self-care); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Irritable Bowel Syndrome (IBS) Treatment Market will witness a robust CAGR of 9.1% , valued at $3.84 billion in 2024 , expected to apprec... Read More

Published Date: OCT-2025 | No Of Pages:157 | $ 4485

Attention Deficit Hyperactivity Disorder (ADHD) Market By Drug Type (Stimulants, Non-Stimulants); By Demographic Group (Children and Adolescents, Adults); By Route of Administration (Oral, Transdermal, Others); By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Platforms); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Attention Deficit Hyperactivity Disorder (ADHD) Market will witness a robust CAGR of 7.5 %, valued at $19.4 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:159 | $ 4485

Primary Immunodeficiency Market By Disease Type (Antibody Deficiencies, Combined Immunodeficiencies, Phagocytic Cell Disorders, Complement Deficiencies, Others); By Treatment Type (Immunoglobulin Replacement Therapy, Targeted Biologics, Hematopoietic Stem Cell Transplantation, Gene Therapy, Supportive Therapies); By Route of Administration (Intravenous, Subcutaneous, Oral, Others); By End User (Hospitals & Specialty Clinics, Homecare Settings, Research & Academic Institutes, Others); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Primary Immunodeficiency Market is projected to witness a robust CAGR of 7.8% , valued at USD 8.9 billion in 2024, and expected to appreciate and reach Read More

Published Date: OCT-2025 | No Of Pages:193 | $ 4485

Thalassemia Market By Type (Alpha Thalassemia, Beta Thalassemia); By Treatment (Blood Transfusion, Iron Chelation Therapy, Gene Therapy, Bone Marrow/Stem Cell Transplantation, Others); By Route of Administration (Oral, Parenteral); By End User (Hospitals, Specialty Clinics, Research & Academic Institutes, Homecare Settings); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Thalassemia Market will witness a steady CAGR of 8.5%, valued at $1.89 billion in 2024 , and is expected to expand and reach $Read More

Published Date: OCT-2025 | No Of Pages:189 | $ 4485

Pediatric Diabetes Therapeutics Market By Type (Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus); By Therapeutic Modality (Insulin Therapy, Oral Hypoglycemics, Adjunctive Therapies, CGM Systems, Insulin Delivery Devices); By Route of Administration (Injectable, Oral, Transdermal); By End User (Hospitals, Pediatric Specialty Clinics, Homecare Settings, Academic & Research Institutes); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Pediatric Diabetes Therapeutics Market will witness a robust CAGR of 8.5 % , valued at $12.6 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:197 | $ 4485

Enzyme Replacement Therapy Market By Product Type (Agalsidase Beta, Imiglucerase, Velaglucerase Alfa, Alglucosidase Alfa, Idursulfase, Others); By Indication (Gaucher Disease, Fabry Disease, Pompe Disease, Mucopolysaccharidoses, Others); By Route of Administration (Intravenous, Subcutaneous); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Enzyme Replacement Therapy (ERT) Market will witness a strong CAGR of 7.3%, valued at approximately $11.8 billion in 2024 , and is p... Read More

Published Date: OCT-2025 | No Of Pages:188 | $ 4485

Fungal Keratitis Treatment Market By Treatment Type (Topical Antifungal Therapy, Systemic Antifungal Therapy, Surgical Interventions, Adjunct Therapies); By Route of Administration (Topical, Oral, Intravenous, Ocular Injections); By End User (Hospitals, Specialty Eye Clinics, Academic and Research Institutes, Ambulatory Surgical Centers); By Geography, Segment Revenue Estimation, Forecast, 2024–2030

Introduction And Strategic Context

The Global Fungal Keratitis Treatment Market will witness a robust CAGR of 6.3 % , valued at USD 1.14 billion in 2024 , expected to appreciate and r... Read More

Published Date: OCT-2025 | No Of Pages:195 | $ 4485

Central Nervous System (CNS) Therapeutics Market By Drug Class (Small Molecule Drugs, Biologics and Advanced Therapies); By Indication (Neurodegenerative Diseases, Psychiatric Disorders, Epilepsy and Seizure Disorders, Multiple Sclerosis, Pain Management and Neuropathic Pain); By Route of Administration (Oral, Injectable, Transdermal/Others); By End User (Hospitals & Specialty Clinics, Retail & Online Pharmacies, Research & Academic Institutes, Mental Health Centers, Military & Veteran Health Systems); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Central Nervous System (CNS) Therapeutics Market will witness a robust CAGR of 8.6 % , valued at USD 138.2 billion in 2024Read More

Published Date: OCT-2025 | No Of Pages:164 | $ 4485

Idiopathic Pulmonary Fibrosis Treatment Market By Drug Type (Antifibrotic Agents, Corticosteroids, Immunosuppressants, Others); By Mechanism of Action (TGF-β Inhibition, Tyrosine Kinase Inhibition, Anti-inflammatory Modulation, Others); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Idiopathic Pulmonary Fibrosis Treatment Market will witness a robust CAGR of 7.8% , valued at $3.1 billion in 2024 , expected to appreciate and reach $5.2 billion ... Read More

Published Date: OCT-2025 | No Of Pages:199 | $ 4485

Crohn’s Disease Therapeutics Market By Drug Class (Aminosalicylates, Corticosteroids, Immunomodulators, Biologics, Small Molecule Therapies, Others); By Route of Administration (Oral, Injectable, Intravenous); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Crohn’s Disease Therapeutics Market will witness a robust CAGR of 6.8% , valued at $14.2 billion in 2024 , and is expected to appre... Read More

Published Date: OCT-2025 | No Of Pages:192 | $ 4485

Type 2 Diabetes Mellitus Treatment Market By Drug Class (Insulin Therapy, Oral Hypoglycemic Agents, GLP-1 Receptor Agonists, Dual Agonists); By Route of Administration (Oral, Injectable, Inhaled); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online); By Geography, Segment Revenue Estimation, Forecast, 2024–2030.

Introduction And Strategic Context

The Global Type 2 Diabetes Mellitus Treatment Market will witness a robust CAGR of 8.23 % , valued at approximately USD 58.5 billion in... Read More

Published Date: OCT-2025 | No Of Pages:184 | $ 4485

1 2 3 4